MVP Recovery LLC -Media

300 West Baltimore Avenue, Media,

About MVP Recovery LLC

MVP Recovery LLC is a rehab center located in Media, PA. Check out the most accurate information and book a visit right now!

Services

Type of Care

Substance use treatment; Treatment for co-occurring substance use plus either serious mental health illness in adults/serious emotional disturbance in children

Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)

Outpatient; Outpatient day treatment or partial hospitalization; Intensive outpatient treatment; Outpatient methadone/buprenorphine or naltrexone treatment; Regular outpatient treatment

Opioid Medications used in Treatment

Buprenorphine used in Treatment; Naltrexone used in Treatment

External Opioid Medications Source

In-network prescribing entity; Other contracted prescribing entity

Type of Alcohol Use Disorder Treatment

This facility administers/prescribes medication for alcohol use disorder

External Source of Medications Used for Alcohol Use Disorder Treatment

In-network prescribing entity; No formal relationship with prescribing entity

Type of Opioid Treatment

Buprenorphine maintenance; Prescribes buprenorphine; Prescribes naltrexone; Relapse prevention with naltrexone; Accepts clients using MAT but prescribed elsewhere; Maintenance service with medically supervised withdrawal after stabilization

Pharmacotherapies

Acamprosate (Campral®); Buprenorphine with naloxone; Buprenorphine without naloxone; Buprenorphine (extended-release, injectable); Naltrexone (oral); Naltrexone (extended-release, injectable); Medication for mental disorders; Non-nicotine smoking/tobacco cessation

Treatment Approaches

Anger management; Cognitive behavioral therapy; Motivational interviewing; Relapse prevention; Substance use disorder counseling; Trauma-related counseling

Facility Operation (e.g., Private, Public)

Private for-profit organization

License/Certification/Accreditation

State Substance use treatment agency

Payment/Insurance/Funding Accepted

Federal, or any government funding for substance use treatment programs; Medicaid; Private health insurance

Assessment/Pre-treatment

Comprehensive mental health assessment; Comprehensive substance use assessment; Screening for substance use; Screening for mental disorders

Testing

Drug and alcohol oral fluid testing; Drug or alcohol urine screening

Transitional Services

Aftercare/continuing care; Discharge Planning; Naloxone and overdose education; Outcome follow-up after discharge

Education and Counseling Services

Substance use disorder education; Individual counseling; Group counseling

Facility Smoking Policy

Smoking permitted without restriction

Age Groups Accepted

Children/Adolescents

Sex Accepted

Female; Male

Facility Vaping Policy

Vaping permitted without restriction

Ancillary Services

Case management service; Mental health services; Transportation assistance

Type of Care

Substance use treatment; Treatment for co-occurring substance use plus either serious mental health illness in adults/serious emotional disturbance in children

Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)

Outpatient; Outpatient day treatment or partial hospitalization; Intensive outpatient treatment; Outpatient methadone/buprenorphine or naltrexone treatment; Regular outpatient treatment

Opioid Medications used in Treatment

Buprenorphine used in Treatment; Naltrexone used in Treatment

External Opioid Medications Source

In-network prescribing entity; Other contracted prescribing entity

Type of Alcohol Use Disorder Treatment

This facility administers/prescribes medication for alcohol use disorder

External Source of Medications Used for Alcohol Use Disorder Treatment

In-network prescribing entity; No formal relationship with prescribing entity

Type of Opioid Treatment

Buprenorphine maintenance; Prescribes buprenorphine; Prescribes naltrexone; Relapse prevention with naltrexone; Accepts clients using MAT but prescribed elsewhere; Maintenance service with medically supervised withdrawal after stabilization

Pharmacotherapies

Acamprosate (Campral®); Buprenorphine with naloxone; Buprenorphine without naloxone; Buprenorphine (extended-release, injectable); Naltrexone (oral); Naltrexone (extended-release, injectable); Medication for mental disorders; Non-nicotine smoking/tobacco cessation

Treatment Approaches

Anger management; Cognitive behavioral therapy; Motivational interviewing; Relapse prevention; Substance use disorder counseling; Trauma-related counseling

Facility Operation (e.g., Private, Public)

Private for-profit organization

License/Certification/Accreditation

State Substance use treatment agency

Payment/Insurance/Funding Accepted

Federal, or any government funding for substance use treatment programs; Medicaid; Private health insurance

Assessment/Pre-treatment

Comprehensive mental health assessment; Comprehensive substance use assessment; Screening for substance use; Screening for mental disorders

Testing

Drug and alcohol oral fluid testing; Drug or alcohol urine screening

Transitional Services

Aftercare/continuing care; Discharge Planning; Naloxone and overdose education; Outcome follow-up after discharge

Education and Counseling Services

Substance use disorder education; Individual counseling; Group counseling

Facility Smoking Policy

Smoking permitted without restriction

Age Groups Accepted

Children/Adolescents

Sex Accepted

Female; Male

Facility Vaping Policy

Vaping permitted without restriction

Ancillary Services

Case management service; Mental health services; Transportation assistance

Send Booking Request

Send Request
300 West Baltimore Avenue, Media,
Claim Listing
Report An Error